Share on StockTwits
 

Equities Research Analysts’ new coverage for Monday, February 24th:

JPMorgan Chase & Co. started coverage on shares of AES Corp. (NYSE:AES). They issued a neutral rating and a $16.00 target price on the stock.

HC Wainwright initiated coverage on shares of Agenus (NASDAQ:AGEN). HC Wainwright issued a buy rating and a $8.00 target price on the stock. The analysts wrote, “We are initiating coverage of Agenus with a BUY rating and a target price of $8. In our opinion, the acquisition of 4-Antibody has propelled the company into the ever exciting field of checkpoint inhibitors. With the addition of 6 lead checkpoint programs, we believe Agenus could soon find itself in the cross hairs of other Pharma/Biotech acquirers. In addition, the company’s proprietary personalized platform technology encompassing cancer and infectious disease vaccines as well as the partnered QS-21 program represent significant value drivers for investors. “With a portfolio of diverse assets, a confluence of milestones anticipated over the next 12-18 months, and a cash position of $85 MM (proforma), we believe Agenus represents an undervalued player with significant upside for the long-term investor.”

Ladenburg Thalmann began coverage on shares of American States Water (NYSE:AWR). The firm issued a buy rating on the stock.

Stifel Nicolaus initiated coverage on shares of Celladon Corp (NASDAQ:CLDN). Stifel Nicolaus issued a buy rating and a $16.00 target price on the stock.

Wedbush began coverage on shares of Celladon Corp (NASDAQ:CLDN). They issued an outperform rating and a $17.00 target price on the stock.

JPMorgan Chase & Co. started coverage on shares of Canadian Solar (NASDAQ:CSIQ). They issued an overweight rating and a $50.00 target price on the stock.

Robert W. Baird started coverage on shares of Dicerna Pharmaceuticals (NASDAQ:DRNA). The firm issued a neutral rating and a $41.00 price target on the stock.

Stifel Nicolaus started coverage on shares of Dicerna Pharmaceuticals (NASDAQ:DRNA). The firm issued a buy rating and a $53.00 price target on the stock.

Jefferies Group began coverage on shares of Dicerna Pharmaceuticals (NASDAQ:DRNA). The firm issued a buy rating on the stock.

HC Wainwright initiated coverage on shares of GenVec (NASDAQ:GNVC). They issued a buy rating on the stock.

Macquarie began coverage on shares of Hilton Worldwide Holdings (NYSE:HLT). The firm issued a neutral rating on the stock.

Credit Suisse assumed coverage on shares of H&R Block (NYSE:HRB). The firm issued an outperform rating and a $37.00 price target on the stock.

Canaccord Genuity began coverage on shares of Lifetime Brands (NASDAQ:LCUT). They issued a buy rating and a $23.00 target price on the stock.

Brean Capital began coverage on shares of Lifetime Brands (NASDAQ:LCUT). The firm issued a buy rating and a $23.00 price target on the stock.

Liberum Capital started coverage on shares of Manx Telecom PLC (LON:MANX). They issued a buy rating and a GBX 180 ($2.99) target price on the stock.

Morgan Stanley assumed coverage on shares of Move (NASDAQ:MOVE). Morgan Stanley issued an equal weight rating on the stock.

KLR Group initiated coverage on shares of Noble Energy (NYSE:NBL). They issued a buy rating and a $91.00 price target on the stock.

ISI Group started coverage on shares of Paccar (NASDAQ:PCAR). The firm issued a buy rating and a $72.00 target price on the stock.

Jefferies Group assumed coverage on shares of Paragon Shipping (NASDAQ:PRGN). The firm issued a buy rating and a $12.00 target price on the stock.

Singular Research initiated coverage on shares of Salem Communications Corp. (NASDAQ:SALM). They issued a buy rating and a $13.00 price target on the stock.

Davy Research started coverage on shares of Sovereign Mines of Africa PLC (LON:SMA). Davy Research issued a neutral rating and a GBX 4 ($0.07) price target on the stock.

Sterne Agee started coverage on shares of Target (NYSE:TGT). The firm issued a neutral rating and a $54.00 target price on the stock.

Standpoint Research began coverage on shares of Yahoo! (NASDAQ:YHOO). They issued a sell rating on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.